Category Archives: Embryonic Stem Cells


Chinese space scientists study human organs in space – Space Daily

Scientists around the world are looking for the "keys" to enable humans to regrow tissues or organs lost due to illness or injury, just like gecko can regrow a tail. Their quest now extends into space. Stem cell research on Tianzhou-1, China's first cargo spacecraft, is far from realizing this dream, but it's the first step to explore the possibility.

Scientists from the Institute of Zoology of the Chinese Academy of Sciences (CAS) are conducting experiments on Tianzhou-1, which launched Thursday, to study the effects of micro-gravity on embryonic stem cell proliferation and differentiation.

The spacecraft is carrying embryonic stem cells and embryoid bodies of mice. Scientists will observe the process of their proliferation and differentiation in space through telescope images. Parallel experiments will be conducted on the ground to compare the results, says lead researcher Duan Enkui.

"We hope to get an initial understanding about the space micro-gravity effects on stem cell proliferation and differentiation," said Duan.

The basis of tissue engineering and regenerative medicine research, stem cell biology is regarded as one of the most important research fields of the 21st Century.

Embryonic stem cells are pluripotent cells that have the potential to become any type of cell in the body. One of the main characteristics of stem cells is their ability to self-renew or multiply while maintaining the potential to develop into other types of cells. Stem cells can become cells of the blood, heart, bones, skin, muscles, brain or other body parts. They are valuable as research tools and might, in future, be used to treat a wide range of ailments.

The study of micro-gravity's effects on the proliferation and differentiation of stem cells is a hot topic in the field of space life science.

"In ground experiments simulating micro-gravity conditions, we found the differentiation ability of mouse embryonic stem cells is enhanced. We also discovered the key gene responsible for this change and the molecular signaling pathway," says Lei Xiaohua, a member of the research team.P "Can we use micro-gravity conditions to realize large-scale proliferation of stem cells and tissue engineering construction? That's what we want to find out," says Lei.

"As the ground experiments are conducted in simulated micro-gravity, we must move the study to a real micro-gravity environment in space to understand how it will affect the proliferation and differentiation of embryonic stem cells."

The experiment might provide a new method to better realize in-vitro expansion of embryonic stem cells, and might explore a new way to apply multi-potent stem cells in tissue engineering and regenerative medicine, Lei says.

"Maybe scientists will be able to induce stem cells to grow into certain tissues or organs in space in the future to serve people on earth. In another scenario, if a human is injured and loses organs in future space migration, the lost organs might be regenerated," says Lei.

Previously, the research team conducted a series of space life science experiments on China's recoverable satellites Sj-8 and Sj-10.

"We expect to continue our research into embryonic stem cells on China's future space station. We aim to try to culture functional tissues, such as heart, kidney, liver and spleen tissues," Lei says.

The current life science experiments on Tianzhou-1 are remotely controlled, which is very difficult, he adds. Scientists hope to enter China's space station in future to personally conduct the experiments.

Source: Xinhua News Agency

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.

Originally posted here:
Chinese space scientists study human organs in space - Space Daily

Can we grow human organs in space? Chinese scientists ask – Shanghai Daily (subscription)

SCIENTISTS around the world are looking for the "keys" to enable humans to regrow tissues or organs lost due to illness or injury, just like gecko can regrow a tail.

Their quest now extends into space.

Stem cell research on Tianzhou-1, China's first cargo spacecraft, is far from realizing this dream, but it's the first step to explore the possibility.

Scientists from the Institute of Zoology of the Chinese Academy of Sciences (CAS) are conducting experiments on Tianzhou-1, which launched Thursday, to study the effects of micro-gravity on embryonic stem cell proliferation and differentiation.

The spacecraft is carrying embryonic stem cells and embryoid bodies of mice. Scientists will observe the process of their proliferation and differentiation in space through telescope images. Parallel experiments will be conducted on the ground to compare the results, says lead researcher Duan Enkui.

"We hope to get an initial understanding about the space micro-gravity effects on stem cell proliferation and differentiation," said Duan.

The basis of tissue engineering and regenerative medicine research, stem cell biology is regarded as one of the most important research fields of the 21st Century.

Embryonic stem cells are pluripotent cells that have the potential to become any type of cell in the body. One of the main characteristics of stem cells is their ability to self-renew or multiply while maintaining the potential to develop into other types of cells. Stem cells can become cells of the blood, heart, bones, skin, muscles, brain or other body parts. They are valuable as research tools and might, in future, be used to treat a wide range of ailments.

The study of micro-gravity's effects on the proliferation and differentiation of stem cells is a hot topic in the field of space life science.

"In ground experiments simulating micro-gravity conditions, we found the differentiation ability of mouse embryonic stem cells is enhanced. We also discovered the key gene responsible for this change and the molecular signaling pathway," says Lei Xiaohua, a member of the research team.P "Can we use micro-gravity conditions to realize large-scale proliferation of stem cells and tissue engineering construction? That's what we want to find out," says Lei.

"As the ground experiments are conducted in simulated micro-gravity, we must move the study to a real micro-gravity environment in space to understand how it will affect the proliferation and differentiation of embryonic stem cells."

The experiment might provide a new method to better realize in-vitro expansion of embryonic stem cells, and might explore a new way to apply multi-potent stem cells in tissue engineering and regenerative medicine, Lei says.

"Maybe scientists will be able to induce stem cells to grow into certain tissues or organs in space in the future to serve people on earth. In another scenario, if a human is injured and loses organs in future space migration, the lost organs might be regenerated," says Lei.

Previously, the research team conducted a series of space life science experiments on China's recoverable satellites Sj-8 and Sj-10.

"We expect to continue our research into embryonic stem cells on China's future space station. We aim to try to culture functional tissues, such as heart, kidney, liver and spleen tissues," Lei says.

The current life science experiments on Tianzhou-1 are remotely controlled, which is very difficult, he adds. Scientists hope to enter China's space station in future to personally conduct the experiments.

Originally posted here:
Can we grow human organs in space? Chinese scientists ask - Shanghai Daily (subscription)

Identical Twins; Not-so-identical Stem Cells – Technology Networks


Technology Networks
Identical Twins; Not-so-identical Stem Cells
Technology Networks
Because they can differentiate into almost any cell type in the body, stem cells have the potential to be used to create healthy cells to treat a number of diseases. But stem cells come in two varieties: embryonic stem cells (ESCs), which are isolated ...

and more »

Read more:
Identical Twins; Not-so-identical Stem Cells - Technology Networks

Human Embryonic Stem Cells Market Is Expected To Rising Demand Owing To The Increasing Incidence Of Genetic … – Press Release Rocket

Grand View Research, Inc. Market Research And Consulting.

According to report published by Grand View Research global Human Embryonic Stem Cells (Hescs) Market is anticipated to reach USD 1.06 billion by 2025.Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025.

GlobalHuman Embryonic Stem Cells (Hescs) Marketis anticipated to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft.

Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.

In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.

Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.

However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.

Full research report on Global Human Embryonic Stem Cells (hESC) Market: http://www.grandviewresearch.com/industry-analysis/human-embryonic-stem-cell-market

Further Key Findings from the Report Suggest:

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Human Embryonic Stem Cells Market on the basis of application and region:

Human Embryonic Stem Cells Application Outlook (Revenue, USD Million, 20142025)

Human Embryonic Stem Cells Regional Outlook (Revenue, USD Million, 20142025)

View Press Release on Global Human Embryonic Stem Cells (hESC) Market By Grand View Research: http://www.grandviewresearch.com/blog/bone-densitometers-market-size-share

About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. Thecompany provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: http://www.grandviewresearch.com

Media Contact Company Name: Grand View Research, Inc. Contact Person: Sherry James, Corporate Sales Specialist U.S.A. Email: Send Email Phone: 1-415-349-0058, Toll Free: 1-888-202-9519 Address:28 2nd Street, Suite 3036 City: San Francisco State: California Country: United States Website: http://www.grandviewresearch.com/industry-analysis/human-embryonic-stem-cell-market

More:
Human Embryonic Stem Cells Market Is Expected To Rising Demand Owing To The Increasing Incidence Of Genetic ... - Press Release Rocket

Ryan Custer may join stem cell study – WDTN

CINCINNATI, Ohio (WDTN) The Wright State basketball player who injured his spinal cord during an accident at a party this month is getting some much needed good news.

According to a post on Facebook, Ryan Custer might be participating in a medical research study that could help with his recovery.

Custers Recovery Care page says Ryan has been approved to participate in a stem cell study at Rush University in Chicago. This, after he shattered his c5 vertebrae jumping into a makeshift pool at a party in Oxford.

The study would use human embryonic stem cells to see if they help patients whove had spinal cord injuries like Custer. According to the studys webpage called SCI star, early lab studies have shown the cells promote partial repair of damaged cord tissue.

There is a time frame for this study. The injection has to be done within 30 days of the injury and those patients must bescreened earlier than that. That means Custer needs to be in Chicago for treatment in the next few weeks.

The Facebook page says as soon as Ryan is able to travel, they will head there. We did reach out to the Rush University. They cannot confirm Ryan has been accepted into the study.

Custers dad is expected to give an update on Ryans condition Tuesday afternoon.

Keep checking WDTN.com for the latest news, weather and sports. To get alerts for breaking news, grab the FREE WDTN News App for iPhone or Android. You can also sign up for email alerts here.

Dont miss another post on Facebook or Twitter for all the latest breaking news

Like Loading...

WDTN.com provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others and keep the conversation on topic and civil. If you see an inappropriate comment, please flag it for our moderators to review.

See the rest here:
Ryan Custer may join stem cell study - WDTN

Brain cells reprogrammed to make dopamine, with goal of Parkinson’s therapy – The San Diego Union-Tribune

In a pioneering study, European scientists have reprogrammed brain cells in mice to correct some of the movement disorders of Parkinsons disease.

The scientists also demonstrated the reprogramming in human brain cells grown in cultures.

In both mice and human cell cultures, the procedure converted brain cells called astrocytes into cells that produce dopamine, a neurotransmitter necessary for movement. Dopamine-making neurons are destroyed in Parkinsons disease; so replacing them should alleviate symptoms.

Like all biomedical research, this approach will require more development and testing before it can be considered for treating actual patients.

The study was published Monday in Nature Biotechnology. Pia Rivetti di Val Cervo was first author, and Ernest Arenas was senior author. Both are of Karolinska Institute in Stockholm, Sweden.

The study can be found online at j.mp/astropark.

Researchers worked on mice that had had their dopamine-making neurons destroyed. They used a viral delivery system to transmit three genes to the astrocytes that reprogrammed some of them into dopamine-making cells.

The next steps to be taken toward achieving this goal include improving reprogramming efficiency, demonstrating the approach on human adult striatal astrocytes, developing systems to selectively target human striatal astrocytes in vivo, and ensuring safety and efficacy in humans, the study concluded.

The study is a more sophisticated version of gene therapy approaches that have previously been investigated for Parkinsons, and is worth pursuing, said Parkinsons disease researcher Andres Bratt-Leal. However, much more work needs to be done before it can be considered for patients, he said. Meanwhile, other therapeutic projects are much closer to clinical testing.

Bratt-Leal is involved in one of those projects, a San Diego-based initiative to reprogram skin cells from Parkinsons patients into embryonic-like cells called induced pluripotent stem cells, and then mature them into the dopamine producing neurons. These neurons will then be implanted into the brains of the patients, if work by the Summit for Stem Cell Foundation succeeds.

Implanting new neurons has shown tremendous promise in animal models and clinical trials using dopamine-producing neurons derived from embryonic stem cells or induced pluripotent stem cells are going to start in the next 1 to 2 years, said Bratt-Leal, the foundations director of research. Gene therapy is promising, but there remain a lot of questions before it is ready for clinical trial.

In a dish, only a fraction of the cells are successfully made into cells which resemble dopamine-producing neurons, Bratt-Leal said. I'd like to know what happens to all the other cells which don't complete that transformation. Are the cells made with gene therapy as good as the neurons we can make from stem cells?

With cell therapy clinical trials around the corner and improvements in gene therapy technology, patients with Parkinson's disease have reasons to stay active and optimistic about the future.

bradley.fikes@sduniontribune.com

(619) 293-1020

Continue reading here:
Brain cells reprogrammed to make dopamine, with goal of Parkinson's therapy - The San Diego Union-Tribune

Human Embryonic Stem Cells (hESC) Market to Reach $1 Billion by 2025 – Application of hESCs as a Promising Donor … – Business Wire (press release)

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Human Embryonic Stem Cells (hESC) Market, 2014 - 2025" report to their offering.

The global human embryonic stem cells (hESCs) market is anticipated to reach USD 1.06 billion by 2025. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft.

Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.

In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.

Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.

However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.

Companies Mentioned

Key Topics Covered:

1 Research Methodology

2 Executive Summary

3 Human Embryonic Stem Cells Market Variables, Trends & Scope

4 Human Embryonic Stem Cells Market: Application Estimates & Trend Analysis

5 Human Embryonic Stem Cells Market: Regional Estimates & Trend Analysis, by Application

6 Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/w7n75n/human_embryonic

Read the rest here:
Human Embryonic Stem Cells (hESC) Market to Reach $1 Billion by 2025 - Application of hESCs as a Promising Donor ... - Business Wire (press release)

Global Human Embryonic Stem Cells Market Size, Growth, Share, Trends and Forecast by 2025- Market Research … – MilTech

The global human embryonic stem cells (hESCs) market is anticipated to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft.

Browse the report: http://www.orbisresearch.com/reports/index/human-embryonic-stem-cells-hesc-market-analysis-by-application-regenerative-medicines-stem-cell-biology-research-tissue-engineering-toxicology-testing-by-country-u-s-uk-germany-japan-china-and-segment-forecasts-2014-2025

Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.

In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.

Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/240830

However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.

Further Key Findings from the Study Suggest:

hESC derivation provides a unique opportunity for early human development studies.

It is believed to hold a substantial potential for regenerative medicine and biopharma.

Differentiated derivatives of these cells are applicable for screening assays in development of novel pharmaceutical moieties.

Screening for mutagenic as well as toxic compounds can also be carried out using such derivatives.

Buy the report@http://www.orbisresearch.com/contact/purchase/240830

Presence of lack of suitable donor organs and tissues for regenerative medicine is expected to increase the demand thus influencing growth.

Stem cell research is anticipated to exhibit fastest growth amongst the other applications.

However, presence of controversies pertaining to their use as a consequence of ethical considerations is responsible for steady growth.

Europe accounts for considerable share of the market, following North America.

As per a recent survey carried out by Swiss government, citizens there are more willing to accept embryonic stem cell research than politicians.

Asia Pacific is anticipated to drive market with fastest YoY growth.

Rising awareness amongst the population and physicians with respect to associated therapies is anticipated to propel progress.

Key players contributing in this market are CellGenix GmbH, International Stem Cell Corporation, Thermo Fisher Scientific, Inc.; Kite Pharma, PromoCell GmbH, and Lonza.

Presence of clinical trial pipeline for embryonic stem cell derived therapy for targeting different diseases is expected to fuel growth.

The diseases targeted include macular degeneration, Parkinsons disease, type I diabetes mellitus, and spinal cord injury.

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello Senior Manager Client Engagements 4144N Central Expressway, Suite 600, Dallas, Texas 75204, U.S.A. Phone No.: +1 (214) 884-6817; +9164101019 Email: sales@orbisresearch.com

Read the original post:
Global Human Embryonic Stem Cells Market Size, Growth, Share, Trends and Forecast by 2025- Market Research ... - MilTech

Human Embryonic Stem Cells Market Size Worth $1.06 Billion by … – Yahoo Finance

SAN FRANCISCO, April 11, 2017 /PRNewswire/ --

The global human embryonic stem cells (hESCs) marketis anticipated to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft.

(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )

Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.

In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.

Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.

However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.

Browse full research report with TOC on "Human Embryonic Stem Cells (hESC) Market Analysis By Application (Regenerative Medicines, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Country (U.S., UK, Germany, Japan, China), And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/human-embryonic-stem-cell-market

Further key findings from the report suggest:

Browse related reports by Grand View Research:

Grand View Research has segmented the human embryonic stem cells market on the basis of application and region:

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. Thecompany provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com

Web: http://www.grandviewresearch.com

The rest is here:
Human Embryonic Stem Cells Market Size Worth $1.06 Billion by ... - Yahoo Finance

Human Embryonic Stem Cells (hESC) Market to Reach $1 Billion by 2025 – Application of hESCs as a Promising Donor … – Yahoo Finance

DUBLIN--(BUSINESS WIRE)--

Research and Markets has announced the addition of the "Human Embryonic Stem Cells (hESC) Market, 2014 - 2025" report to their offering.

The global human embryonic stem cells (hESCs) market is anticipated to reach USD 1.06 billion by 2025. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft.

Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.

In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.

Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.

However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.

Companies Mentioned

Key Topics Covered:

1 Research Methodology

2 Executive Summary

3 Human Embryonic Stem Cells Market Variables, Trends & Scope

4 Human Embryonic Stem Cells Market: Application Estimates & Trend Analysis

5 Human Embryonic Stem Cells Market: Regional Estimates & Trend Analysis, by Application

6 Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/w7n75n/human_embryonic

View source version on businesswire.com: http://www.businesswire.com/news/home/20170407005275/en/

Here is the original post:
Human Embryonic Stem Cells (hESC) Market to Reach $1 Billion by 2025 - Application of hESCs as a Promising Donor ... - Yahoo Finance